Successful EU SUBA Clinical Study
Filed with ASX ·
6ix hasn’t read this filing yet.
Mayne Pharma Group Ltd. on 6ix
Later from Mayne Pharma
- 2015 Appendix 4E & Annual Report
- Mayne Pharma receives FDA approval for Doryx MPC tablets
- MYX receives first generic approval of Tikosyn capsules
- MYX announces acquisition of US generic product portfolio
- Completion institutional entitlement offer and placement
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma